In vitro evaluation of the efficacy of idarubicin in human tumour cells from patients with low-grade non-Hodgkin's lymphoma
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03484.x/fullpdf
Reference30 articles.
1. Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug- resistant leukemia cells;Berman;Blood,1992
2. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center;Berman;Seminars in Oncology,1989
3. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia;Bosanquet;Blood,1996
4. Correlation of bcl-2 with P-glycoprotein expression in chronic lymphocytic leukaemia and other haematological neoplasms but of neither marker with ex vivo chemosensitivity or patient survival;Bosanquet;Leukemia and Lymphoma,1996
5. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric cytotoxicity assay (FMCA);Csoka;Gynecologic Oncology,1994
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of potential inhibitors targeting BRAF-V600E mutant melanoma cells;Journal of the American Academy of Dermatology;2021-04
2. The transport of Idarubicin therapeutic agent using a novel graphene sheet as a drug delivery platform through a biomembrane;Journal of Molecular Liquids;2021-02
3. Two dimensional porous frameworks of graphyne family as therapeutic delivery vehicles for Idarubicin biomolecule in silico: Density functional theory and molecular dynamics simulation;Journal of Molecular Liquids;2020-12
4. Structural investigation of idarubicin–DNA interaction: Spectroscopic and molecular docking study;International Journal of Biological Macromolecules;2013-09
5. In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia;Anti-Cancer Drugs;2005-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3